Sodium Bicarbonate NDC 0409-6637

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-6637Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-6637Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-6637-14	00409663714	10 CARTON in 1 PACKAGE (0409-6637-14) / 1 SYRINGE in 1 CARTON / 50 mL in 1 SYRINGE (0409-6637-24)Marketed from Jul 23, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Bicarbonate
Generic name (nonproprietary): sodium bicarbonate
Active ingredients: Sodium bicarbonate — 84 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202494
Marketing start: Jul 23, 2020
Marketing end: Nov 30, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
Identifiers: Product ID 0409-6637_f79ec8cb-b6a3-4ffb-bccf-d39f59d65621SPL ID f79ec8cb-b6a3-4ffb-bccf-d39f59d65621SPL set ID ea20a5eb-641e-48cd-bcfa-74c04c45dfdaRxCUI 727995, 792582UNII 8MDF5V39QO
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409663714 followed by a unit qualifier and the quantity

Package 00409-6637-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 6, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. Sodium bicarbonate …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202494

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202494
Product	Strength	Form · route	Labeler	Product NDC
Sodium Bicarbonate	Sodium bicarbonate 84 mg/mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7266